Literature DB >> 8001544

Activation of a GTP-binding protein and a GTP-binding-protein-coupled receptor kinase (beta-adrenergic-receptor kinase-1) by a muscarinic receptor m2 mutant lacking phosphorylation sites.

K Kameyama1, K Haga, T Haga, O Moro, W Sadée.   

Abstract

A mutant of the human muscarinic acetylcholine receptor m2 subtype (m2 receptor), lacking a large part of the third intracellular loop, was expressed and purified using the baculovirus/insect cell culture system. The mutant was not phosphorylated by beta-adrenergic-receptor kinase, as expected from the previous assignment of phosphorylation sites to the central part of the third intracellular loop. However, the m2 receptor mutant was capable of stimulating beta-adrenergic-receptor-kinase-1-mediated phosphorylation of a glutathione S-transferase fusion protein containing the m2 phosphorylation sites in an agonist-dependent manner. Both mutant and wild-type m2 receptors reconstituted with the guanine-nucleotide-binding regulatory proteins (G protein), G(o) and G(i)2, displayed guanine-nucleotide-sensitive high-affinity agonist binding, as assessed by displacement of [3H]quinuclidinyl-benzilate binding with carbamoylcholine, and both stimulated guanosine 5'-3-O-[35S]thiotriphosphate ([35S]GTP[S]) binding in the presence of carbamoylcholine and GDP. The Ki values of carbamoylcholine effects on [3H]quinuclidinyl-benzilate binding were indistinguishable for the mutant and wild-type m2 receptors. Moreover, the phosphorylation of the wild-type m2 receptor by beta-adrenergic-receptor kinase-1 did not affect m2 interaction with G proteins as assessed by the binding of [3H]quinuclidinyl benzilate or [35S]GTP[S]. These results indicate that (a) the m2 receptor serves both as an activator and as a substrate of beta-adrenergic-receptor kinase, and (b) a large part of the third intracellular loop of the m2 receptor does not contribute to interaction with G proteins and its phosphorylation by beta-adrenergic-receptor kinase does not uncouple the receptor and G proteins in reconstituted lipid vesicles.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8001544     DOI: 10.1111/j.1432-1033.1994.tb20050.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  6 in total

1.  Role of receptor kinase in short-term desensitization of cardiac muscarinic K+ channels expressed in Chinese hamster ovary cells.

Authors:  Z Shui; I A Khan; H Tsuga; T Haga; M R Boyett
Journal:  J Physiol       Date:  1998-03-01       Impact factor: 5.182

2.  Proteoliposome-based selection of a recombinant antibody fragment against the human M2 muscarinic acetylcholine receptor.

Authors:  Yayoi Nomura; Takatoshi Arakawa; Tomoya Hino; Hitomi Abe; Yoshiko Nakada-Nakura; Yumi Sato; Hiroko Iwanari; Mitsunori Shiroishi; Hidetsugu Asada; Tatsuro Shimamura; Takeshi Murata; Takuya Kobayashi; Takao Hamakubo; So Iwata; Norimichi Nomura
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2014-12

3.  Receptor kinase-dependent desensitization of the muscarinic K+ current in rat atrial cells.

Authors:  Z Shui; M R Boyett; W J Zang; T Haga; K Kameyama
Journal:  J Physiol       Date:  1995-09-01       Impact factor: 5.182

4.  Identification of an Ascaris G protein-coupled acetylcholine receptor with atypical muscarinic pharmacology.

Authors:  Michael J Kimber; Laura Sayegh; Fouad El-Shehabi; Chuanzhe Song; Mostafa Zamanian; Debra J Woods; Tim A Day; Paula Ribeiro
Journal:  Int J Parasitol       Date:  2009-03-25       Impact factor: 3.981

5.  Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist.

Authors:  Kazuko Haga; Andrew C Kruse; Hidetsugu Asada; Takami Yurugi-Kobayashi; Mitsunori Shiroishi; Cheng Zhang; William I Weis; Tetsuji Okada; Brian K Kobilka; Tatsuya Haga; Takuya Kobayashi
Journal:  Nature       Date:  2012-01-25       Impact factor: 49.962

Review 6.  Molecular properties of muscarinic acetylcholine receptors.

Authors:  Tatsuya Haga
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2013       Impact factor: 3.493

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.